Donoghoe Nicholas's Form 4 filing
AbbVie Inc. (ABBV) · filed Aug 7, 2025
- Accession no.
- 0001415889-25-021280
- Filed
- Aug 7, 2025
- Trade date
- Aug 5, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.64M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Donoghoe NicholasCIK 0001762951 | Officer (EVP, CHIEF BUS/STRAT OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −3,234.17 | $198.27 | −$641,238.89 | 68,308 | Direct | |
| Aug 5, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −10,061 | $198.59 | −$1,998,013.99 | 58,247 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.